Daniel Mollenkamp, Author at CBD-Intel

Curaleaf in hot water with FDA over ‘improper health claims’

Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...

FDA gathers in opposing strong views and cannabis-related anecdotes

Written by Daniel Mollenkamp || 25th July 2019 || Business briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Business briefing

The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views ...

Massachusetts upsets farmers by insisting on no CBD in food products

Written by Daniel Mollenkamp || 8th July 2019 || Regulatory briefing |

Massachusetts

North America

United States

Regulation and Legislation

Regulatory briefing

The Massachusetts Department of Agricultural Resources has confirmed that farmers and processors in the state cannot add CBD to food ingredients ...

USDA counsel says states cannot halt transport of legally-grown hemp

Written by Daniel Mollenkamp || 25th June 2019 || Regulatory briefing |

Colorado

Idaho

North America

Oregon

United States

West Virginia

Regulation and Legislation

Regulatory briefing

US states and tribal territories have no right to stop the transportation of legal hemp that conforms with US Department of Agriculture (USDA) guidelines or was produced under the terms of the 2014 Farm Bill ...

Poll finds very few Americans think they should be denied access to CBD

Written by Daniel Mollenkamp || 20th June 2019 || Business briefing |

North America

United States

Market Research

Business briefing

Only 2% of Americans think CBD should not be available to consumers, according to a recent poll by the survey company Gallup ...

Banned or not? eBay appears to defy its own CBD prohibition

Written by Daniel Mollenkamp || 11th June 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

Despite eBay’s claims to the contrary, CBD products appear to remain very much obtainable through the online marketplace. But are they the real thing? ...

Selected CBD businesses invited to test new payment and financial services

Written by Daniel Mollenkamp || 5th June 2019 || Business briefing |

North America

United States

Companies

Business briefing

Payments company Square is studying the potential for providing financial services to the CBD sector, with an invite-only beta test currently under way ...

Is the NFL about to relax its stance on CBD?

Written by Daniel Mollenkamp || 4th June 2019 || Business briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Business briefing

CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American...

Bank associations pressure US Congress for cannabis banking reform

Written by Daniel Mollenkamp || 29th May 2019 || Regulatory briefing |

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North America

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Puerto Rico

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

United States

Utah

Vermont

Virginia

Washington

Washington D.C.

West Virginia

Wisconsin

Wyoming

Policy and Politics

Regulation and Legislation

Regulatory briefing

Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform ...

Martial arts company to help research use of CBD for athletes

Written by Daniel Mollenkamp || 24th May 2019 || Business briefing |

Canada

North America

United States

Marketing and Retailing

Public Health and Medicine

Business briefing

Aurora Cannabis is to collaborate with Ultimate Fighting Championship (UFC), a mixed martial arts promotions company headquartered in Las Vegas, on studies of CBD’s possible usefulness in treating pain and inflammation and in recovery and...

Judge’s ruling sets a precedent in patent law for cannabis extracts

Written by Daniel Mollenkamp || 24th May 2019 || Regulatory briefing |

Colorado

North America

United States

Regulation and Legislation

Regulatory briefing

Cannabinoid extracts require human intervention to change them from their natural state, a judge has ruled in a dispute that will help develop case law ...

US alcohol bureau won’t approve CBD-infused drinks – at least for now

Written by Daniel Mollenkamp || 20th May 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Alcohol and Tobacco Tax and Trade Bureau (ATTB) has said it will not approve the use of "hemp-CBD" in alcohol products ...

Toronto Wolfpack becomes first sports team to field its own CBD product line

Written by Daniel Mollenkamp || 20th May 2019 || Business briefing |

Canada

North America

United Kingdom

Companies

Marketing and Retailing

Business briefing

A couple of Canadian companies are working with a professional rugby league team to bring cannabidiol products to athletes – and the general public ...

Tennessee brings ‘smoking hemp’ into its legal lexicon

Written by Daniel Mollenkamp || 17th May 2019 || Regulatory briefing |

North America

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Tennessee legislature has enacted a bill which defines "smoking hemp" ...

It’s a chain reaction as US retailers join the rush to stock CBD products

Written by Daniel Mollenkamp || 15th May 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

CBD has taken off in US retail, with a number of major chains – including some unexpected ones – taking opportunities to cash in on the surging popularity of CBD products ...

Legal CBD firms face cash chaos as US Bank cancels their card accounts

Written by Daniel Mollenkamp || 14th May 2019 || Business briefing |

North America

United States

Companies

Policy and Politics

Regulation and Legislation

Business briefing

Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal ...

US attorney general favours bid to let states decide cannabis and CBD policy

Written by Daniel Mollenkamp || 16th April 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies ...

US Postal Service offers guidance on mail delivery of CBD products

Written by Daniel Mollenkamp || 4th April 2019 || Business briefing |

North America

United States

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Business briefing

Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the...

FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims

Written by Daniel Mollenkamp || 3rd April 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims” ...

Mainstream US drugstore chains announce plans to sell CBD

Written by Daniel Mollenkamp || 29th March 2019 || Business briefing |

Alabama

California

Colorado

Illinois

Indiana

Kentucky

Maryland

New Mexico

North America

Oregon

South Carolina

Tennessee

United States

Vermont

Companies

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Business briefing

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has...

Canadian company Isodiol buys up California’s CBD Naturals

Written by Daniel Mollenkamp || 21st March 2019 || Business briefing |

Canada

North America

United States

Companies

Business briefing

Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals ...

Takeovers and investments bloom as hemp takes root across North America

Written by Daniel Mollenkamp || 5th March 2019 || Business briefing |

Canada

North America

United States

Companies

Business briefing

North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests ...

State by state, US Farm Bill delivers different strokes for different folks

Written by Daniel Mollenkamp || 4th March 2019 || Regulatory briefing |

Colorado

New York

North America

Pennsylvania

Puerto Rico

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth ...

Confusion abounds in the tangle of US states’ CBD enforcement

Written by Daniel Mollenkamp || 26th February 2019 || Regulatory briefing |

Alabama

Idaho

Maine

Michigan

Nebraska

New York

North America

Ohio

South Carolina

Tennessee

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers ...

Global CBD rules will get tougher, then normalise, expert predicts

Written by Daniel Mollenkamp || 20th February 2019 || Business briefing |

Europe

France

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Business briefing

Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert ...

CBD company signs deal with mall giant to open branded stores across US

Written by Daniel Mollenkamp || 13th February 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

Ohio-based CBD and cannabis company Green Growth Brands (GGB) is to open 108 retail locations in shopping malls across the US this year, including some of the most high-profile shopping locations in the country ...

US veterans urge CBD legalisation in Georgia, Tennessee drafts CBD bills

Written by Daniel Mollenkamp || 28th January 2019 || Regulatory briefing |

Georgia

North America

Tennessee

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised ...

CBD to enter the big-time with coffee ads at the Super Bowl

Written by Daniel Mollenkamp || 28th January 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

A series of advertisements for CBD products will be seen at Sunday’s Super Bowl LIII between the New England Patriots and the LA Rams, powerfully demonstrating their arrival in the US mainstream ...

Congress passes US Farm Bill with Hemp Farming Act intact

Written by Daniel Mollenkamp || 14th December 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry ...

Charlotte’s Web can spread through drugstores, with help of Farm Bill

Written by Daniel Mollenkamp || 10th December 2018 || Business briefing |

North America

United States

Washington

Companies

Business briefing

Charlotte’s Web Holdings, which claims to be the market leader in “innovative hemp-based, CBD wellness products”, says it expects to add national drugstores to its thousands of locations in the US soon ...

US federal government soliciting information for CBD research

Written by Daniel Mollenkamp || 22nd November 2018 || Business briefing |

Canada

North America

United States

Market Research

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Business briefing

Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute...

Exit Sessions – could the departure of the AG be good news for cannabis?

Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

With the ousting of attorney general Jeff Sessions from the Trump administration, members of the US cannabis industry have perked up, hoping the anti-cannabis agenda will exit with him ...

Michigan says yes, North Dakota says no to recreational cannabis

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in...

CBD.io teams up with vape expo for major Las Vegas show

Written by Daniel Mollenkamp || 17th October 2018 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

A major CBD show is to be held in Las Vegas next month in what is billed as “an epic collaboration of two industries”. The CBD.io event will take place on 9th and 10th November in conjunction with...

Hemp still on federal narcotics list as Congressional deadline lapses

Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty ...

Massachusetts growers losing patience over licensing hold-ups

Written by Daniel Mollenkamp || 18th September 2018 || Business briefing |

Massachusetts

North America

United States

Policy and Politics

Regulation and Legislation

Business briefing

Cannabis growers in Massachusetts have indicated they may sue the state’s Cannabis Control Commission over a dispute that appears to have delayed the start of legal sales there ...

‘Cannabis with nicotine affects brain differently than either on its own’

Written by Daniel Mollenkamp || 11th September 2018 || Business briefing |

North America

United States

Public Health and Medicine

Business briefing

Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco ...

Potentially deadly rat poison found in synthetic cannabinoids, says FDA

Written by Daniel Mollenkamp || 30th July 2018 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says ...

If FDA approves CBD drug it could be a game-changer for the vapour industry

Written by Daniel Mollenkamp || 31st May 2018 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The first ever FDA-approved cannabis-derived product came a step nearer reality when an independent panel at the agency recommended it as a “safe” and “efficacious” treatment for childhood seizures ...

Is PMI preparing for a future move into the cannabis business?

Written by Daniel Mollenkamp || 13th March 2018 || Business briefing |

North America

United States

Business briefing

In our latest report on developments in the legal cannabis market, CBD-Intel considers whether PMI may be setting up a future move in that direction. We also look at the potential dangers of synthetic cannabis products ...

Pharmaceutical firm to breeze into vaping by buying e-liquid and hemp oil business

Written by Daniel Mollenkamp || 22nd November 2017 || Business briefing |

Canada

North America

United States

Companies

Business briefing

Isodiol International, a Canadian-based pharmaceutical producer, is to enter the vaping industry through the acquisition of US e-liquid firm Bradley’s Bioscience ...

Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 25th July 2019 || Business briefing |

Written by Daniel Mollenkamp || 8th July 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 25th June 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 20th June 2019 || Business briefing |

Written by Daniel Mollenkamp || 11th June 2019 || Business briefing |

Written by Daniel Mollenkamp || 5th June 2019 || Business briefing |

Written by Daniel Mollenkamp || 4th June 2019 || Business briefing |

Written by Daniel Mollenkamp || 29th May 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 24th May 2019 || Business briefing |

Written by Daniel Mollenkamp || 24th May 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 20th May 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 20th May 2019 || Business briefing |

Written by Daniel Mollenkamp || 17th May 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 15th May 2019 || Business briefing |

Written by Daniel Mollenkamp || 14th May 2019 || Business briefing |

Written by Daniel Mollenkamp || 16th April 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 4th April 2019 || Business briefing |

Written by Daniel Mollenkamp || 3rd April 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 29th March 2019 || Business briefing |

Written by Daniel Mollenkamp || 21st March 2019 || Business briefing |

Written by Daniel Mollenkamp || 5th March 2019 || Business briefing |

Written by Daniel Mollenkamp || 4th March 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 26th February 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 20th February 2019 || Business briefing |

Written by Daniel Mollenkamp || 13th February 2019 || Business briefing |

Written by Daniel Mollenkamp || 28th January 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 28th January 2019 || Business briefing |

Written by Daniel Mollenkamp || 14th December 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 10th December 2018 || Business briefing |

Written by Daniel Mollenkamp || 22nd November 2018 || Business briefing |

Written by Daniel Mollenkamp || 15th November 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 17th October 2018 || Business briefing |

Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 18th September 2018 || Business briefing |

Written by Daniel Mollenkamp || 11th September 2018 || Business briefing |

Written by Daniel Mollenkamp || 30th July 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 31st May 2018 || Regulatory briefing |

Written by Daniel Mollenkamp || 13th March 2018 || Business briefing |

Written by Daniel Mollenkamp || 22nd November 2017 || Business briefing |

Sign up to our newsletter

Subscribe for the latest industry updates

Don't miss out